MYASTHENIA GRAVIS
Clinical trials for MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Myasthenia gravis drug trial halted early after enrolling only 6 people
Disease control TerminatedThis study tested a drug called tolebrutinib in adults with moderate-to-severe generalized myasthenia gravis, a condition that causes muscle weakness. Participants took either the drug or a placebo for 26 weeks, with a follow-up period of up to 2 years. The trial was terminated e…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Failed trial aims to ease Drug's harsh side effects for Muscle-Weakening disease
Symptom relief TerminatedThis study tested if adding the anti-nausea drug ondansetron could reduce stomach-related side effects like nausea and diarrhea caused by pyridostigmine, a standard medication for myasthenia gravis. It involved adults with the disease who either were experiencing these side effec…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: DAS-MG, Inc • Aim: Symptom relief
Last updated Apr 13, 2026 20:21 UTC